NASDAQ · CARM
Carisma Therapeutics, Inc.
Healthcare · Biotechnology
$0.00
Down-$0.00 (-12.00%)
Updated Aug 15, 2026, 6:37 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.04M
- P/E ratio
- -0.04
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.56
- Volume
- 2.26K
- Avg. volume
- 1.18M
Price performance
CARM price history
1M range · 19 trading sessions · Daily adjusted prices
CARM closed at $0.00 after 19 trading sessions, down 57.69% for the selected period.
- Last close
- $0.00
- Period change
- -57.69%
- Period low
- $0.00
- Period high
- $0.01
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $0.0022 | $0.0022 | $0.0022 | $0.0022 | 2.26K |
| Aug 13, 2026 | $0.0023 | $0.0023 | $0.0022 | $0.0022 | 111.68K |
| Aug 11, 2026 | $0.0025 | $0.0025 | $0.0025 | $0.0025 | 577 |
| Aug 10, 2026 | $0.0025 | $0.0025 | $0.0025 | $0.0025 | 2.33K |
| Aug 7, 2026 | $0.0022 | $0.0025 | $0.0022 | $0.0025 | 48.65K |
| Aug 6, 2026 | $0.0025 | $0.0025 | $0.0025 | $0.0025 | 160 |
| Aug 5, 2026 | $0.0025 | $0.0025 | $0.0025 | $0.0025 | 4.5K |
| Aug 4, 2026 | $0.0025 | $0.0025 | $0.0025 | $0.0025 | 1.19K |
| Aug 3, 2026 | $0.0025 | $0.0025 | $0.0025 | $0.0025 | 2.76K |
| Jul 30, 2026 | $0.0025 | $0.004 | $0.0025 | $0.0025 | 7.48K |
| Jul 29, 2026 | $0.0022 | $0.0022 | $0.0022 | $0.0022 | 1.85K |
| Jul 28, 2026 | $0.0045 | $0.0045 | $0.0045 | $0.0045 | 810 |
| Jul 27, 2026 | $0.0045 | $0.0045 | $0.0045 | $0.0045 | 18.81K |
| Jul 24, 2026 | $0.0051 | $0.0051 | $0.0045 | $0.0045 | 3.18K |
| Jul 23, 2026 | $0.0051 | $0.0051 | $0.0051 | $0.0051 | 11.49K |
| Jul 22, 2026 | $0.0042 | $0.0051 | $0.0042 | $0.0045 | 35.87K |
| Jul 21, 2026 | $0.0051 | $0.0051 | $0.0042 | $0.0042 | 11.68K |
| Jul 20, 2026 | $0.0042 | $0.0042 | $0.0042 | $0.0042 | 10.89K |
| Jul 17, 2026 | $0.0052 | $0.0052 | $0.0052 | $0.0052 | 22.19K |
Latest CARM news
The latest Smart Investors Daily articles mentioning CARM.
Stock researchResearch & News · Analysis
Loading stock research…
